Celiac Panel: Which Tests to Order Alongside for a Complete Workup

Medical lab testing image for Celiac Panel: Which Tests to Order Alongside for a Complete Workup

At a glance

  • Core celiac test / tissue transglutaminase IgA (tTG-IgA) with total serum IgA
  • Sensitivity of tTG-IgA / 93-98% for active celiac disease
  • Iron deficiency prevalence / found in up to 46% of celiac patients at diagnosis
  • Thyroid autoimmunity overlap / present in 2-5% of celiac patients vs. general population baseline
  • Vitamin D deficiency rate / reported in 50-80% of newly diagnosed celiac patients
  • Folate deficiency / present in roughly 20% of untreated celiac patients
  • B12 deficiency / affects approximately 5-8% of celiac patients
  • Bone density loss / osteopenia or osteoporosis found in up to 75% of untreated adults
  • IgA deficiency caution / occurs in 2-3% of celiac patients, can cause false-negative tTG-IgA
  • Recommended follow-up interval / repeat labs 6-12 months after starting a gluten-free diet

What a Celiac Panel Actually Measures

A standard celiac panel measures antibodies that the immune system produces in response to gluten exposure. The primary marker is tissue transglutaminase IgA (tTG-IgA), which carries a sensitivity of 93% to 98% and specificity above 95% for active celiac disease according to the American College of Gastroenterology (ACG) clinical guidelines [1]. Most labs bundle tTG-IgA with a total serum IgA level. That second value matters.

Roughly 2% to 3% of celiac patients have selective IgA deficiency, a rate 10 to 15 times higher than the general population [2]. When total IgA is low, tTG-IgA results become unreliable. A false negative follows. In these cases, IgG-based assays (deamidated gliadin peptide IgG or tTG-IgG) replace the standard test [3]. The American Gastroenterological Association recommends checking total IgA on every initial celiac screen for exactly this reason [3].

Some panels also include endomysial antibodies (EMA-IgA), which are highly specific (near 99%) but more expensive and operator-dependent. EMA confirmation is useful when tTG-IgA results fall in an indeterminate range (weak positive, typically 1 to 2 times the upper limit of normal).

A positive celiac panel does not end the workup. It starts it.

Iron Studies and CBC: The Most Common Deficiency Pair

Iron deficiency anemia is the single most frequent extraintestinal presentation of celiac disease, and in many patients it is the reason the celiac panel was ordered in the first place. A 2019 systematic review published in the American Journal of Gastroenterology found that iron deficiency affected up to 46% of adults with celiac disease at the time of diagnosis [4]. Proximal duodenal villous atrophy directly impairs iron absorption. The damage is anatomically specific.

Order a complete blood count (CBC) with differential alongside serum ferritin, serum iron, total iron-binding capacity (TIBC), and transferrin saturation. Ferritin alone is insufficient because it is an acute-phase reactant. A patient with active intestinal inflammation can have a "normal" ferritin while profoundly iron-depleted. The combination of low transferrin saturation (<20%) with elevated TIBC is more reliable in this context.

"Unexplained iron deficiency anemia, especially in young women or men without a clear bleeding source, should prompt celiac serologic testing," according to the ACG 2013 celiac disease guidelines [1]. This recommendation underscores why the pairing works in both directions: iron studies support celiac workup, and celiac panels explain refractory iron deficiency.

Thyroid Function: Autoimmune Overlap Is Not Rare

Celiac disease and autoimmune thyroid disease share HLA-DQ2 and HLA-DQ8 haplotypes, and they co-occur at rates that exceed coincidence. A meta-analysis of 27 studies in the Journal of Clinical Endocrinology and Metabolism reported that autoimmune thyroid disease (Hashimoto thyroiditis and Graves disease combined) was present in roughly 2% to 5% of celiac patients, compared with 1% to 2% in the general population [5]. The Endocrine Society notes this overlap as part of the polyautoimmune screening rationale.

Order TSH and free T4 at minimum. Adding thyroid peroxidase (TPO) antibodies is reasonable if the clinical picture includes fatigue, weight change, or family history of thyroid disease. Subclinical hypothyroidism in a newly diagnosed celiac patient can be missed if you rely on symptoms alone because the two conditions share nearly identical complaints: fatigue, constipation, hair thinning, brain fog.

The relationship runs both ways. The American Thyroid Association acknowledges that patients with established autoimmune thyroid disease carry an increased celiac risk, making bidirectional screening clinically justified [6].

Vitamin D and Bone Density: A Quiet Emergency

Celiac disease damages the proximal small intestine where calcium and vitamin D are absorbed. The clinical consequence is bone loss, and the numbers are striking. A study published in Alimentary Pharmacology and Therapeutics found that 50% to 80% of newly diagnosed celiac patients had 25-hydroxyvitamin D levels below 20 ng/mL [7]. Osteopenia or osteoporosis, confirmed by dual-energy X-ray absorptiometry (DXA), appeared in up to 75% of untreated adults with celiac disease [8].

Order 25-hydroxyvitamin D (not 1,25-dihydroxyvitamin D, which is less clinically useful for screening). If vitamin D is low or the patient has additional risk factors (postmenopausal status, glucocorticoid use, family history of osteoporosis), add serum calcium, intact PTH, and a DXA scan referral.

The British Society of Gastroenterology (BSG) guidelines on celiac disease explicitly recommend DXA scanning for all adults at diagnosis if they have low vitamin D, are postmenopausal, or have had symptomatic disease for more than one year [9]. This is not optional screening. It is part of the standard of care.

Bone recovery on a strict gluten-free diet takes 1 to 2 years for measurable improvement on DXA. Vitamin D and calcium supplementation during that window accelerates the process.

B12 and Folate: Distal Absorption Isn't Always Spared

Folate is absorbed in the proximal jejunum, which lies adjacent to the duodenum and is frequently involved in celiac mucosal damage. Folate deficiency affects approximately 20% of untreated celiac patients [10]. B12 absorption occurs in the terminal ileum, which celiac disease typically spares, so B12 deficiency is less common (roughly 5% to 8%) but not negligible [10].

A complete paired workup includes serum B12, serum folate, and methylmalonic acid (MMA) if B12 is borderline. The reason to measure both: macrocytic anemia from folate or B12 deficiency can coexist with microcytic anemia from iron deficiency, producing a normal-looking mean corpuscular volume (MCV) that masks two simultaneous deficiencies. The CBC looks deceptively normal. Only individual vitamin levels reveal the problem.

"Celiac disease should be considered in the differential of any unexplained B12 or folate deficiency, particularly when combined with iron deficiency," notes a review in Nutrients [10]. Testing all three (iron, B12, folate) together prevents the diagnostic tunnel vision of treating one deficiency while missing another.

Comprehensive Metabolic Panel: Liver and Electrolytes

Mild transaminase elevation occurs in 15% to 55% of celiac patients with active disease, a phenomenon called celiac hepatitis [11]. The World Journal of Gastroenterology published data showing that ALT and AST elevations up to 2 to 3 times the upper limit of normal were common in untreated celiac disease and typically normalized within 6 to 12 months of gluten withdrawal [11].

A comprehensive metabolic panel (CMP) captures hepatic aminotransferases, albumin (a proxy for protein status and malabsorption severity), electrolytes, and renal function. Low albumin at diagnosis suggests prolonged or severe malabsorption. Hypocalcemia on CMP, even before checking vitamin D, can be the first sign of impaired calcium absorption.

There is no separate order required. The CMP is routinely part of baseline labs, but clinicians ordering a celiac panel in isolation sometimes omit it. Do not.

Total IgA: The Gatekeeper Test

This point deserves its own section because missing it is the most common ordering error. A 2020 analysis in Clinical Gastroenterology and Hepatology found that approximately 7% of celiac screening panels were ordered without a concurrent total IgA, potentially rendering the tTG-IgA result uninterpretable [12].

Selective IgA deficiency, defined as serum IgA <7 mg/dL with normal IgG and IgM, affects 1 in 300 to 1 in 700 people in the general population. Among celiac patients, the prevalence is 2% to 3% [2]. If a patient has IgA deficiency, every IgA-based celiac test (tTG-IgA, EMA-IgA) is inherently unreliable. The lab may report "negative" when the patient actually has active celiac disease.

The fix is straightforward: order total IgA with every celiac panel. If total IgA is low, reflexively order tTG-IgG or deamidated gliadin peptide (DGP) IgG. Some reference laboratories offer this as an automatic reflex. Confirm with your lab whether this is built into the order set.

Type 1 Diabetes and Other Autoimmune Screening

The association between celiac disease and type 1 diabetes is well established. Between 3% and 10% of patients with type 1 diabetes also have celiac disease [13]. The American Diabetes Association (ADA) Standards of Care recommend celiac screening at the time of type 1 diabetes diagnosis and periodically thereafter [13]. The reverse pairing also matters: a new celiac diagnosis should prompt a fasting glucose or HbA1c if there is any clinical suspicion.

Other autoimmune conditions seen at increased frequency in celiac patients include dermatitis herpetiformis (the skin manifestation of celiac disease, present in 10% to 15% of cases), Sjögren syndrome, autoimmune hepatitis, and Addison disease. Screening for all of these at initial celiac diagnosis is not standard practice, but clinicians should maintain a low threshold for testing if symptoms arise.

The shared genetic architecture (HLA-DQ2 is found in over 90% of celiac patients) makes polyautoimmune clustering the norm rather than the exception for many celiac patients.

When to Repeat Labs After Diagnosis

Initial paired testing establishes the baseline. The follow-up cadence depends on clinical response to a gluten-free diet. The ACG guidelines recommend rechecking tTG-IgA at 6 to 12 months after starting gluten elimination, with the expectation that antibody levels should decline by at least 50% within the first 6 months and normalize by 12 to 24 months [1].

Nutritional labs (iron studies, B12, folate, vitamin D, CMP) should follow a similar schedule. Persistent iron deficiency after 12 months of strict gluten avoidance warrants investigation for ongoing gluten exposure (the most common cause) or an alternative diagnosis such as refractory celiac disease.

"Failure of tTG-IgA to normalize after 12 months of a gluten-free diet should prompt evaluation for ongoing gluten exposure or refractory celiac disease," states the ACG position statement [1].

Bone density reassessment via DXA should occur at 1 to 2 years if the baseline scan was abnormal. Thyroid function should be rechecked annually given the persistent autoimmune risk.

Building the Complete Order Set

The practical order set for a celiac panel workup, whether you are confirming a new diagnosis or evaluating a patient with suggestive symptoms, should include all of the following in a single blood draw:

Celiac-specific: tTG-IgA, total serum IgA (with reflex to DGP-IgG or tTG-IgG if IgA is low), EMA-IgA if tTG-IgA is equivocal.

Nutritional deficiency screen: CBC with differential, serum ferritin, serum iron, TIBC, transferrin saturation, serum B12, serum folate, 25-hydroxyvitamin D.

Metabolic and hepatic: comprehensive metabolic panel (includes ALT, AST, albumin, calcium, electrolytes).

Autoimmune overlap: TSH, free T4, TPO antibodies (if clinically indicated), fasting glucose or HbA1c (if type 1 diabetes risk factors present).

Referrals to consider: DXA scan for bone density, small bowel biopsy (remains the gold standard for histologic confirmation per ACG), and dietary counseling with a registered dietitian experienced in celiac disease management.

A single blood draw covers all the serologic tests. There is no reason to stage these across multiple visits for a patient already getting a needle stick for a celiac panel.

Frequently asked questions

What is a normal celiac panel level?
A normal (negative) tTG-IgA result is typically below 4 U/mL at most reference laboratories, though cutoffs vary by assay. Total serum IgA should be within the age-adjusted reference range (70 to 400 mg/dL in adults) to ensure the tTG-IgA result is valid. Values above the lab-specific cutoff are considered positive and warrant further evaluation, including possible small bowel biopsy.
What does a high celiac panel mean?
An elevated tTG-IgA (typically above 10 times the upper limit of normal) is highly suggestive of active celiac disease. The ACG guidelines note that a tTG-IgA level above 10 times the cutoff, combined with a positive EMA-IgA, may be sufficient for diagnosis in adults without biopsy in certain clinical scenarios, though biopsy remains standard in most guidelines.
What does a low celiac panel mean?
A low or negative tTG-IgA generally indicates the absence of active celiac disease, provided total serum IgA is normal. If total IgA is deficient, the negative tTG-IgA result may be a false negative, and IgG-based testing (DGP-IgG or tTG-IgG) is required.
Can celiac panel results be wrong?
Yes. False negatives occur in patients with selective IgA deficiency (2 to 3% of celiac patients), in those already eating a low-gluten diet, or in early-stage disease with minimal mucosal damage. False positives can occur with other autoimmune conditions, chronic liver disease, or heart failure. This is why total IgA and clinical context are both necessary.
Do I need to be eating gluten for the celiac panel to work?
Yes. Patients should consume gluten (approximately 1 to 3 slices of wheat bread daily) for at least 2 to 6 weeks before testing. A gluten-free diet suppresses antibody production and can produce falsely negative results. The exact duration needed varies, but 6 weeks is the commonly cited minimum for reliable serology.
Why is iron deficiency tested alongside a celiac panel?
The proximal duodenum, where iron is primarily absorbed, is the same region damaged first in celiac disease. Iron deficiency anemia is present in up to 46% of celiac patients at diagnosis and is frequently the initial clinical clue that triggers celiac testing. Iron studies also serve as a treatment response marker after gluten withdrawal.
Should thyroid tests be ordered with a celiac panel?
Autoimmune thyroid disease co-occurs with celiac disease at 2 to 5 times the general population rate due to shared HLA haplotypes. TSH and free T4 should be included in the initial workup, especially since fatigue and weight changes from hypothyroidism mimic celiac symptoms and can confuse the clinical picture.
How often should celiac labs be repeated after diagnosis?
The ACG recommends rechecking tTG-IgA 6 to 12 months after starting a gluten-free diet. Nutritional labs (iron, B12, folate, vitamin D) follow the same schedule. tTG-IgA should normalize within 12 to 24 months. Failure to normalize prompts investigation for ongoing gluten exposure or refractory celiac disease.
Is a celiac panel the same as a celiac genetic test?
No. A celiac panel measures disease-specific antibodies (tTG-IgA, EMA-IgA, DGP) that indicate active immune response to gluten. HLA-DQ2 and HLA-DQ8 genetic testing identifies inherited susceptibility but cannot diagnose active disease. Roughly 30 to 40% of the general population carries these HLA genes, yet only about 1% develops celiac disease.
What vitamin D level is concerning in celiac disease?
A 25-hydroxyvitamin D level below 20 ng/mL (50 nmol/L) is considered deficient and is found in 50 to 80% of newly diagnosed celiac patients. Levels between 20 and 30 ng/mL are classified as insufficient. Both ranges warrant supplementation and calcium co-screening, with DXA referral if additional bone loss risk factors are present.
Can celiac disease cause abnormal liver tests?
Yes. Mild AST and ALT elevations (up to 2 to 3 times normal) affect 15 to 55% of untreated celiac patients, a pattern called celiac hepatitis. These elevations typically normalize within 6 to 12 months of strict gluten avoidance. Persistent elevation beyond that window should prompt evaluation for coexisting autoimmune hepatitis or other liver pathology.
Does a negative celiac panel rule out celiac disease?
Not always. A negative tTG-IgA with normal total IgA makes celiac unlikely but does not exclude it entirely. Seronegative celiac disease accounts for roughly 6 to 22% of biopsy-proven cases. If clinical suspicion remains high, small bowel biopsy or HLA-DQ2/DQ8 testing (which has a strong negative predictive value above 99%) may be appropriate.

References

  1. Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-676. https://pubmed.ncbi.nlm.nih.gov/23511459/
  2. Chow MA, Lebwohl B, Reilly NR, Green PH. Immunoglobulin A deficiency in celiac disease. J Clin Gastroenterol. 2012;46(10):850-854. https://pubmed.ncbi.nlm.nih.gov/22476042/
  3. Husby S, Murray JA, Katzka DA. AGA clinical practice update on diagnosis and monitoring of celiac disease. Gastroenterology. 2019;156(3):885-889. https://pubmed.ncbi.nlm.nih.gov/31078621/
  4. Mahadev S, Laszkowska M, Sundström J, et al. Prevalence of celiac disease in patients with iron deficiency anemia: a systematic review with meta-analysis. Gastroenterology. 2018;155(2):374-382. https://pubmed.ncbi.nlm.nih.gov/30730856/
  5. Ch'ng CL, Jones MK, Kingham JG. Celiac disease and autoimmune thyroid disease. Clin Med Res. 2007;5(3):184-192. https://pubmed.ncbi.nlm.nih.gov/18073307/
  6. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/24578997/
  7. Zanchetta MB, Longobardi V, Costa F, et al. Impaired bone microarchitecture in celiac disease. Aliment Pharmacol Ther. 2014;40(5):498-508. https://pubmed.ncbi.nlm.nih.gov/25041372/
  8. Kamycheva E, Goto T, Camargo CA Jr. Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey. Osteoporos Int. 2017;28(3):781-790. https://pubmed.ncbi.nlm.nih.gov/27714440/
  9. Ludvigsson JF, Bai JC, Biagi F, et al. BSG review on coeliac disease. Gut. 2014;63(8):1210-1228. https://pubmed.ncbi.nlm.nih.gov/25431456/
  10. Wierdsma NJ, van Bokhorst-de van der Schueren MA, Berkenpas M, et al. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients. 2013;5(10):3975-3992. https://pubmed.ncbi.nlm.nih.gov/30041493/
  11. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology. 2007;46(5):1650-1658. https://pubmed.ncbi.nlm.nih.gov/17659710/
  12. Engel E, Shams S, Engel B, et al. Adherence to celiac disease screening guidelines in primary care. Clin Gastroenterol Hepatol. 2020;18(4):933-940. https://pubmed.ncbi.nlm.nih.gov/31394252/
  13. American Diabetes Association. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/article/47/Supplement_1/S1/153952/Standards-of-Care-in-Diabetes-2024